MedTech Startup NOWDiagnostics Secures $22.5M to Commercialize OTC Diagnostic Tests nextdigitalhealth.com

NOWDiagnostics (NOWDx), a US-based medical technology startup developing over-the-counter (OTC) and point-of-care (POC) diagnostic test kits, has secured $22.5M in an oversubscribed series B funding round to commercialize at-home diagnostic testing kits.

As the company announced on Tuesday, July 9, the new funding will also support the development of new diagnostic innovations, increase the number of tests, and strategically hire new staff to support its mission.

Led by Robert Weigle, John Miller, Jody Berry, Ph.D, Michele Roe, and Vicki Thompson, the startup’s latest funding round was spearheaded by DigitalDx Ventures, with the support of notable investor companies, including Kompass Kapital Management and LabCorp Venture Fund.